"In the USA the FDA will meet end of November for its decision regarding the approval of TAF 25MG for hbv. I would assume that it will be available a few I month later in the EU. Currently DESCOVY 25mg TAF plus 200mg emtricitabine is a..."
Are you sure you want to delete your ?
You will no longer be able to add new data to this tracker.